605:
502:
475:
512:
336:
315:
163:
429:
404:
657:
22:
74:
617:
53:
84:
778:
181:
284:
542:
559:
711:
are where people discuss how to make content on
Knowledge the best that it can be. You can use this page to start a discussion with others about how to improve the "
773:
595:
585:
803:
758:
386:
376:
798:
788:
768:
635:
549:
220:
207:
763:
753:
140:
793:
783:
743:
554:
130:
748:
352:
738:
194:
106:
525:
480:
214:
537:
343:
320:
708:
630:
485:
675:
435:
409:
97:
58:
667:
275:
533:
on
Knowledge. If you would like to participate, please visit the project page, where you can join the ongoing discussions.
691:
188:
175:
33:
201:
21:
671:
604:
247:
227:
39:
726:
517:
440:
414:
681:
351:
on
Knowledge. If you would like to participate, please visit the project page, where you can join
105:
on
Knowledge. If you would like to participate, please visit the project page, where you can join
719:
501:
474:
685:
233:
89:
264:
240:
162:
732:
530:
335:
314:
348:
622:
428:
403:
612:
507:
79:
666:
to the subject of this article. Relevant policies and guidelines may include
529:, a collaborative effort to improve the coverage of topics relating to the
712:
102:
73:
52:
651:
15:
182:
Knowledge:Requested articles/Business and economics/Companies
603:
664:
contributor may be personally or professionally connected
779:
Start-Class United States articles of Low-importance
704:
Start a discussion about improving the
Omnicare page
347:, a collaborative effort to improve the coverage of
101:, a collaborative effort to improve the coverage of
438:, a project which is currently considered to be
8:
221:Category:Company articles needing infoboxes
208:Category:Company articles needing attention
19:
469:
398:
309:
170:Here are some tasks awaiting attention:
148:
47:
471:
400:
311:
49:
774:Low-importance United States articles
246:Help expand stub articles located at
7:
804:Articles with connected contributors
759:Low-importance pharmacology articles
523:This article is within the scope of
434:This article is within the scope of
341:This article is within the scope of
195:Category:Unassessed company articles
95:This article is within the scope of
570:Knowledge:WikiProject United States
38:It is of interest to the following
799:WikiProject United States articles
789:Low-importance Cincinnati articles
769:Start-Class United States articles
573:Template:WikiProject United States
361:Knowledge:WikiProject Pharmacology
14:
764:WikiProject Pharmacology articles
754:Start-Class pharmacology articles
364:Template:WikiProject Pharmacology
655:
615:
510:
500:
473:
427:
402:
334:
313:
272:Tag company talk pages with the
161:
82:
72:
51:
20:
794:WikiProject Cincinnati articles
784:Start-Class Cincinnati articles
744:Low-importance company articles
590:This article has been rated as
450:Knowledge:WikiProject Retailing
381:This article has been rated as
135:This article has been rated as
115:Knowledge:WikiProject Companies
749:WikiProject Companies articles
453:Template:WikiProject Retailing
261:Tag company articles with the
118:Template:WikiProject Companies
1:
628:This article is supported by
355:and see a list of open tasks.
109:and see a list of open tasks.
739:Start-Class company articles
152:WikiProject Companies To-do:
820:
596:project's importance scale
387:project's importance scale
141:project's importance scale
611:
589:
526:WikiProject United States
495:
422:
380:
329:
147:
134:
67:
46:
662:The following Knowledge
531:United States of America
344:WikiProject Pharmacology
631:WikiProject Cincinnati
608:
576:United States articles
248:Category:Company stubs
28:This article is rated
676:neutral point of view
607:
436:WikiProject Retailing
367:pharmacology articles
285:requests for comments
276:WikiProject Companies
98:WikiProject Companies
668:conflict of interest
518:United States portal
544:Articles Requested!
721:Start a discussion
609:
456:Retailing articles
34:content assessment
700:
699:
650:
649:
646:
645:
642:
641:
468:
467:
464:
463:
397:
396:
393:
392:
308:
307:
304:
303:
300:
299:
296:
295:
811:
724:
722:
659:
658:
652:
625:
620:
619:
618:
578:
577:
574:
571:
568:
520:
515:
514:
513:
504:
497:
496:
491:
488:
477:
470:
458:
457:
454:
451:
448:
431:
424:
423:
418:
406:
399:
369:
368:
365:
362:
359:
338:
331:
330:
325:
317:
310:
279:
268:
234:Portal:Companies
176:Article requests
165:
158:
157:
149:
123:
122:
121:company articles
119:
116:
113:
92:
90:Companies portal
87:
86:
85:
76:
69:
68:
63:
55:
48:
31:
25:
24:
16:
819:
818:
814:
813:
812:
810:
809:
808:
729:
728:
727:
725:
720:
718:
717:
656:
621:
616:
614:
575:
572:
569:
566:
565:
564:
550:Become a Member
516:
511:
509:
489:
483:
455:
452:
449:
446:
445:
412:
366:
363:
360:
357:
356:
323:
292:
289:
273:
262:
120:
117:
114:
111:
110:
88:
83:
81:
61:
32:on Knowledge's
29:
12:
11:
5:
817:
815:
807:
806:
801:
796:
791:
786:
781:
776:
771:
766:
761:
756:
751:
746:
741:
731:
730:
706:
705:
702:
701:
698:
697:
696:
695:
660:
648:
647:
644:
643:
640:
639:
636:Low-importance
627:
626:
610:
600:
599:
592:Low-importance
588:
582:
581:
579:
563:
562:
557:
552:
547:
540:
538:Template Usage
534:
522:
521:
505:
493:
492:
490:Low‑importance
478:
466:
465:
462:
461:
459:
432:
420:
419:
407:
395:
394:
391:
390:
383:Low-importance
379:
373:
372:
370:
353:the discussion
339:
327:
326:
324:Low‑importance
318:
306:
305:
302:
301:
298:
297:
294:
293:
291:
290:
288:
287:
281:
280:project banner
270:
258:
250:
236:
223:
210:
197:
184:
169:
167:
166:
154:
153:
145:
144:
137:Low-importance
133:
127:
126:
124:
107:the discussion
94:
93:
77:
65:
64:
62:Low‑importance
56:
44:
43:
37:
26:
13:
10:
9:
6:
4:
3:
2:
816:
805:
802:
800:
797:
795:
792:
790:
787:
785:
782:
780:
777:
775:
772:
770:
767:
765:
762:
760:
757:
755:
752:
750:
747:
745:
742:
740:
737:
736:
734:
723:
716:
714:
710:
703:
693:
690:
687:
683:
680:
679:
677:
673:
672:autobiography
669:
665:
661:
654:
653:
637:
634:(assessed as
633:
632:
624:
613:
606:
602:
601:
597:
593:
587:
584:
583:
580:
567:United States
561:
558:
556:
553:
551:
548:
546:
545:
541:
539:
536:
535:
532:
528:
527:
519:
508:
506:
503:
499:
498:
494:
487:
482:
481:United States
479:
476:
472:
460:
443:
442:
437:
433:
430:
426:
425:
421:
416:
411:
408:
405:
401:
388:
384:
378:
375:
374:
371:
354:
350:
346:
345:
340:
337:
333:
332:
328:
322:
319:
316:
312:
286:
282:
277:
271:
266:
260:
259:
257:
255:
251:
249:
245:
243:
242:
237:
235:
232:
230:
229:
224:
222:
219:
217:
216:
211:
209:
206:
204:
203:
198:
196:
193:
191:
190:
185:
183:
180:
178:
177:
172:
171:
168:
164:
160:
159:
156:
155:
151:
150:
146:
142:
138:
132:
129:
128:
125:
108:
104:
100:
99:
91:
80:
78:
75:
71:
70:
66:
60:
57:
54:
50:
45:
41:
35:
27:
23:
18:
17:
707:
688:
663:
629:
591:
555:Project Talk
543:
524:
439:
382:
358:Pharmacology
349:Pharmacology
342:
321:Pharmacology
267:|Companies}}
253:
252:
239:
238:
226:
225:
213:
212:
200:
199:
187:
186:
174:
173:
136:
96:
40:WikiProjects
623:Ohio portal
30:Start-class
733:Categories
709:Talk pages
486:Cincinnati
447:Retailing
410:Retailing
112:Companies
103:companies
59:Companies
715:" page.
713:Omnicare
692:contribs
441:inactive
415:inactive
269:template
228:Maintain
202:Copyedit
682:Jldanon
594:on the
385:on the
283:Answer
215:Infobox
139:on the
674:, and
560:Alerts
265:portal
189:Assess
36:scale.
254:Other
241:Stubs
686:talk
678:.
586:Low
377:Low
131:Low
735::
670:,
638:).
484::
278:}}
274:{{
263:{{
694:)
689:·
684:(
598:.
444:.
417:)
413:(
389:.
256::
244::
231::
218::
205::
192::
179::
143:.
42::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
